An older diabetes treatment called lixisenatide resulted in less progression of motor disability after 12 months in patients in an early stage of the disease Erin Clack is a Staff Editor for PEOPLE.

FOR THOSE WITH NEUROLOGICAL AND MOTOR DISABILITIES. IT BEGAN MORE THAN 20 YEARS AGO BY A LOCAL COUPLE LOOKING FOR A WAY TO HELP THEIR SON AFTER HE WAS DIAGNOSED WITH CEREBRAL PALSY. MEET VICKI AND JOE ...

A recent study published in The New England Journal of Medicine has demonstrated that lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may slow the progression of motor disability in ...

Please provide your email address to receive an email when new articles are posted on . Students with a chronic illness, sensory or motor disability or multiple disabilities often experience ...

Patients with early Parkinson disease who received lixisenatide had a decrease in motor disability progression, but they also experienced gastrointestinal side effects. Lixisenatide vs placebo is ...

FARGO — North Dakota State University students are making the holidays a lot easier for children of all abilities. Playing with toys isn't possible at times for children with physical and motor ...